This trial assesses whether a tailored MRI protocol that eliminates one or more aspects of current mpMRI technique is just as effective as the standard mpMRI protocol for cancer detection.
1 Primary · 0 Secondary · Reporting Duration: through study completion, an average of 1 year
302 Total Participants · 1 Treatment Group
Primary Treatment: restriction spectrum imaging (RSI) · No Placebo Group · Phase 2
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: